It has been suggested that altered interleukin (IL) regulation may be involved in the pathogenesis of schizophrenia. In this cross-sectional, case-controlled study, patients with schizophrenia and a control group of healthy subjects, matched by age, sex and body mass index, were evaluated. The levels of IL-1α and IL-2 in blood serum were measured by enzyme-linked immunosorbent assay. The fasting serum IL-2 levels were significantly higher in patients with schizophrenia compared with the control subjects, but there was no difference between the fasting serum levels of IL-1α in patients with schizophrenia and the control subjects. Our results suggest that patients with schizophrenia have altered IL-2, but not IL-1α, regulation.
CazzulloCLScaroneSGrassiBVismaraCTrabattoniDClericiM: Cytokines production in chronic schizophrenia patients with or without paranoid behaviour. Prog Neuropsychopharmacol Biol Psychiatry1998; 22: 947–957
2.
MullerNRiedelMAckenheilMSchwarzMJ: The role of immune function in schizophrenia: an overview. Eur Arch Psychiatry Clin Neurosci1999; 249 (Suppl 4): 62–68
3.
WilkeIAroltVRothermundtMWeitzschCHornbergMKirchnerH: Investigations of cytokine production in whole blood cultures of paranoid and residual schizophrenic patients. Eur Arch Psychiatry Clin Neurosci1996; 246: 279–284
4.
BarakVBarakYLevineJNismanBRoismanI: Changes in interleukin-1 beta and soluble interleukin-2 receptor levels in CSF and serum of schizophrenic patients. J Basic Clin Physiol Pharmacol1995; 6: 61–69
5.
HornbergMAroltVWilkeIKruseAKirchnerH: Production of interferons and lymphokines in leukocyte cultures of patients with schizophrenia. Schizophr Res1995; 15: 237–242
6.
GanguliRBrarJSRabinBS: Immune abnormalities in schizophrenia: evidence for the autoimmune hypothesis. Harv Rev Psychiatry1994; 2: 70–83
7.
NikkilaHVMullerKAhokasARimonRAnderssonLC: Increased frequency of activated lymphocytes in the cerebrospinal fluid of patients with acute schizophrenia. Schizophr Res2001; 49: 99–105
8.
TheodoropoulouSSpanakosGBaxevanisCNEconomouMGritzapisADPapamichailMP: Cytokine serum levels, autologous mixed lymphocyte reaction and surface marker analysis in never medicated and chronically medicated schizophrenic patients. Schizophr Res2001; 47: 13–25
9.
LinAKenisGBignottiSTuraGJDe JongRBosmansE: The inflammatory response system in treatment-resistant schizophrenia: increased serum interleukin-6. Schizophr Res1998; 32: 9–15
10.
MaesMChiavettoL BocchioBignottiSTuraG BattisaPioliRBoinF: Effects of atypical antipsychotics on the inflammatory response system in schizophrenic patients resistant to treatment with typical neuroleptics. Eur Neuropsychopharmacol2000; 10: 119–124
11.
RothermundtMAroltVWeitzschCEckhoffDKirchnerH: Immunological dysfunction in schizophrenia: a systematic approach. Neuropsychobiology1998; 37: 186–193
12.
RothermundtMAroltVLeadbeaterJPetersMRudolfSKirchnerH: Cytokine production in unmedicated and treated schizophrenic patients. Neuroreport2000; 11: 3385–3388
13.
O'DonnellMCCattsSVWardPBLiebertBLloydAWakefieldD: Increased production of interleukin-2 (IL-2) but not soluble interleukin-2 receptors (sIL-2R) in unmedicated patients with schizophrenia and schizophreniform disorder. Psychiatry Res1996; 65: 171–178
14.
McAllisterCGvan KammenDPRehnTJMillerALGurklisJKelleyME: Increases in CSF levels of interleukin-2 in schizophrenia: effects of recurrence of psychosis and medication status. Am J Psychiatry1995; 152: 1291–1297
15.
BesslerHLeventalZKarpLModaiIDjaldettiMWeizmanA: Cytokine production in drug-free and neuroleptic-treated schizophrenic patients. Biol Psychiatry1995; 38: 297–302
16.
BakerIMasseranoJWyattRJ: Serum cytokine concentrations in patients with schizophrenia. Schizophr Res1996; 20: 199–203
17.
NaudinJMegeJLAzorinJMDassaD: Elevated circulating levels of IL-6 in schizophrenia. Schizophr Res1996; 20: 269–273
18.
KimYKLeeMSSuhKY: Decreased interleukin-2 production in Korean schizophrenic patients. Biol Psychiatry1998; 43: 701–704
19.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th edn.Washington: The American Psychiatric Association, 1994
20.
KronfolZRemickDG: Cytokines and the brain: implications for clinical psychiatry. Am J Psychiatry2000; 157: 683–694
21.
GanguliRBrarJSChengappaKNYangZWNimgaonkarVLRabinBS: Autoimmunity in schizophrenia: a review of recent findings. Ann Med1993; 25: 489–496
22.
SirotaPSchildKElizurADjaldettiMFishmanP: Increased interleukin-1 and interleukin-3 like activity in schizophrenic patients. Prog Neuropsychopharmacol Biol Psychiatry1995; 19: 75–83
23.
LicinioJSeibylJPAltemusMCharneyDSKrystalJH: Elevated CSF levels of interleukin-2 in neuroleptic-free schizophrenic patients. Am J Psychiatry1993; 150: 1408–1410
24.
KimYKKimLLeeMS: Relationships between interleukins, neurotransmitters and psychopathology in drug-free male schizophrenics. Schizophr Res2000; 44: 165–175
